License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

End User/Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2009 American Medical Association (AMA). All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the AMA.

You, your employees and agents are authorized to use CPT only as contained in the following authorized materials including but not limited to CGS fee schedules, general communications, Medicare Bulletin, and related materials internally within your organization within the United States for the sole use by yourself, employees, and agents. Use is limited to use in Medicare, Medicaid, or other programs administered by the Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized here in must be obtained through the AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60610. Applications are available at the AMA website.

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a)(June 1995) and DFARS 227.7202-3(a)June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department Federal procurements.

AMA Disclaimer of Warranties and Liabilities.

CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. AMA warrants that due to the nature of CPT, it does not manipulate or process dates, therefore there is no Year 2000 issue with CPT. AMA disclaims responsibility for any errors in CPT that may arise as a result of CPT being used in conjunction with any software and/or hardware system that is not Year 2000 compliant. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CGS or the CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

CMS Disclaimer

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT must be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

This license will terminate upon notice to you if you violate the terms of this license. The AMA is a third party beneficiary to this license.

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

End User License Agreement

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "I ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "I DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN.

IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

Subject to the terms and conditions contained in this Agreement, you, your employees, and agents are authorized to use CDT-4 only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT-4 is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT-4. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.
Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT-4 for resale and/or license, transferring copies of CDT-4 to any party not bound by this agreement, creating any modified or derivative work of CDT-4, or making any commercial use of CDT-4. License to use CDT-4 for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association website.
Applicable Federal Acquisition Regulation Clauses (FARS)\Department of Defense Federal Acquisition Regulation Supplement (DFARS) Restrictions Apply to Government use. Please click here to see all U.S. Government Rights Provisions.
ADA DISCLAIMER OF WARRANTIES AND LIABILITIES. CDT-4 is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CDT-4. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for the software, including any CDT-4 and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third-party beneficiary to this Agreement.
CMS DISCLAIMER. The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT-4 should be addressed to the ADA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CDT-4. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I ACCEPT". If you do not agree to the terms and conditions, you may not access or use the software. Instead, you must click below on the button labeled "I DO NOT ACCEPT" and exit from this computer screen.

Print | Bookmark | Font Size: + | –

Final Rule CMS-1713-F – Standard Written Orders

On January 1, 2020, new rules took effect governing written orders for all durable medical equipment, prosthetics, orthotics and supplies (DMEPOS). Suppliers have asked questions about the new standard written order (SWO) and other details outlined in the Standard Documentation Requirements Policy Article (A55426). The following Q&A is intended to provide answers to those frequently asked questions.

Click on a question to expand or Show All / Close All

Can a DME supplier dispense an item on a verbal dispensing order or must all orders now be in writing before dispensing?
- For items that do not require a WOPD, a supplier may dispense an item without a written order. However, a SWO must be communicated to the supplier prior to claim submission. Note that suppliers should be aware that state laws, rules or regulations may require an order before dispensing an item.
  
  Originally published: 03.12.2020
  Revised: 12.01.2025
The new standard written order (SWO) has multiple elements, one of which is the "order date." What should suppliers use for this date?
- Ideally, it should be reflective of when the order was first communicated to the supplier, in order to support the dates of service on the claim.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
What will reviewers use when there's an Order Date (based on the phone call from the TP) and then the TP elects to enter a date of their signature?
- While frequency is no longer a required order element, the SWO does require Quantity to be Dispensed for those items where more than one (1) item is dispensed or where dispensing occurs on a periodic basis (e.g., dressings, drugs, supplies, etc). Note also that while the SWO has a limited number of required order elements, suppliers/providers are permitted to add elements that may provide clarity for issues such as LON, frequency of use, dosage form/strength, refills frequency, etc.
  
  Suppliers may also wish to consult state law or regulation since some states may have additional requirements for the elements of an order/prescription.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
The CMS final rule CMS-1713-F does not speak to any requirement for frequency of item dispensed. If frequency is no longer required, then would a new order be required for every dispense?
- While frequency is no longer a required order element, the SWO does require Quantity to be Dispensed for those items where more than one (1) item is dispensed or where dispensing occurs on a periodic basis (e.g., dressings, drugs, supplies, etc). Note also that while the SWO has a limited number of required order elements, suppliers/providers are permitted to add elements that may provide clarity for issues such as LON, frequency of use, dosage form/strength, refills frequency, etc.
  
  Suppliers may also wish to consult state law or regulation since some states may have additional requirements for the elements of an order/prescription.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
With LON no longer a requirement on the order/prescription, are orders good for lifetime?
- Suppliers are reminded that length of need (LON) is not necessarily equated with the need for a new prescription. Note that some LCDs and NCDs time-limit prescriptions (i.e., the LCD or NCD stipulates that a new prescription is needed every XX months). In addition, there may be state laws, rules or regulations governing the valid length of a prescription. For LON specifically, reviewers will look to the medical records to determine LON.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
With respect to the "quantity to be dispensed, if applicable" requirement on the SWO, would it suffice to state that the quantity is "2 per day" or does the quantity have to read a specific number for a month supply, e.g., "60 per month"?
- Either description of quantity would suffice; however, for claim review purposes, expressing the quantity as a weekly or monthly amount is preferable. Note that the "if applicable" applies to drugs, dressings and other DMEPOS items where the dispensed quantity is typically more than one (1) item or that dispensing happens on a recurring basis. Consult the applicable LCD and related Policy Article for additional details.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
How do the DME MACs define "treating physician?" For example, a surgeon in the hospital provides supplies that are needed immediately post-op but following discharge, the beneficiary sees their primary care provider for continued care. Will the patient's primary care practitioner be considered the "treating practitioner" for subsequent supply orders?
- Per the example, if the patient's primary care practitioner has knowledge of, and documentation to support (e.g., face-to-face) the condition that requires his or her writing an order/prescription, there is no preclusion to the patient's primary care practitioner providing subsequent orders/prescriptions.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
For items subject to the face-to-face encounter and written order prior to delivery requirement, must the SWO be signed by the same treating practitioner who completed the face-to-face encounter?
- For power mobility devices, the treating practitioner that conducted the face-to-face encounter must complete the SWO.
  
  For items other than power mobility devices that will appear on the "Required Face-to-Face Encounter and Written Order Prior to Delivery List," the treating practitioner that conducted the face-to-face encounter does not need to be the prescriber for the DMEPOS item; however, to demonstrate compliance with the regulation, the prescriber must:
  - Verify that a qualifying face-to-face encounter occurred within the 6-months prior to the date of their prescription; and,
  - Have documentation of the qualifying face-to-face encounter that was conducted.
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
If a patient experiences a change in treating practitioners, and a SWO is generated by the patient's supplier that prepopulates the wrong treating practitioner's name, is it acceptable for the supplier to strike through the wrong name, fill in the correct name, sign and date the change and submit the corrected order to the patient's treating practitioner for signature?
- Yes, it is acceptable to use standard clinical practice to strike through and provide the updated information.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
I am a treating practitioner but also a supplier. Do I have to write an SWO to myself to dispense DMEPOS?
- No. The SWO regulations do not require that a treating practitioner (e.g. MD/DO or NP/PA/CNS) who is also the supplier to create a separate SWO so long as the elements of a SWO is included in the beneficiary's medical record.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
Does the NPI of the MD/DO/DPM who is both the prescriber and supplier need to be in the patient's chart on the ordered DOS? Physicians typically do not include the prescribing practitioner's NPI in the medical records.
- The SWO, or in this question the medical record serving as the SWO, requires either the NPI or the name of the treating practitioner. If the treating practitioner's name is included in the medical records, there is no need for the NPI to be included as well.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
The final rule CMS-1713-F mentions a "Master List of DMEPOS Items Potentially Subject to Face-To-Face Encounter and Written Orders Prior to Delivery and/or Prior Authorization Requirements", a "Required Face-to-Face Encounter and Written Order Prior to Delivery List" and a "Required Prior Authorization List." Can you provide more information?
- With the final rule CMS-1713-F, CMS set out criteria for identifying DMEPOS items potentially subject to face-to-face encounters and written order prior to delivery, in addition to prior authorization. These criteria define the DMEPOS items on the Master List, which is updated annually. From this Master List, CMS creates two Required Lists – a "Required Face-to-Face Encounter and Written Order Prior to Delivery List" and a "Required Prior Authorization List." The lists are available on the CMS website.
  
  Originally published: 03.12.2020
  Revised: 12.01.2025
For power mobility devices, are suppliers permitted to use a template for the SWO, like the previous 7-element order (7EO) template, so long as the information is completed by the treating practitioner?
- DME MAC Response: For power mobility devices, the treating practitioner must complete the elements of the SWO. A supplier may create a template for use by the treating practitioner to complete the SWO elements. For items other than power mobility devices, the supplier may prepare the SWO for the treating practitioner's signature.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
Is it permissible for the DMEPOS base item and all of the options and accessories to be ordered on one SWO?
- The DME MAC prefer that the base item and all separately billed options and accessories be included on a single SWO; however, CMS final rule CMS-1713-F does allow for separately billed options and accessories to be on a different SWO.
  
  Originally published: 03.12.2020
  Reviewed: 12.01.2025
The final rule indicates there must be a face-to-face encounter with the treating practitioner within 6 months prior to the SWO being written for PMD. Does the date of the face-to-face encounter mean the day the treating practitioner saw the patient, or could it be the date that the treating practitioner countersigned the licensed/certified medical practitioner (LCMP) evaluation, if later than the treating practitioner's face-to-face encounter?
- As noted in the question, the final rule CMS-1713-F indicates there must be a qualifying face-to-face encounter with the treating practitioner within six (6) months prior to the SWO being written for PMD. The final rule CMS-1713-F defines a face-to-face encounter as an in-person or telehealth encounter, and defines a treating practitioner as both physicians, defined in section 1861(r)(1) of the Act, and non-physician practitioners (that is, PA, NP, and CNS) defined in section 1861(aa)(5) of the Act. The final rule CMS-1713-F makes no allowance for other dates resetting this timeframe, such as the treating practitioner's co-signature and agreement/disagreement with an LCMP evaluation.
  
  To accommodate the requirements at 42 CFR 410.38, when the treating practitioner sees the beneficiary, regardless of whether a referral to an LCMP is made, that visit date starts the six (6) month timeline for completion of the SWO. If the treating practitioner chooses to refer the beneficiary to an LCMP for a mobility evaluation, the treating physician's co-signature, dating and indicating agreement or disagreement with the LCMP evaluation must occur within this six (6) month timeframe. In cases where the LCMP evaluation is being adopted into the physician's documentation to substantiate the need for the item, the SWO may not be written until the LCMP report is signed, dated and agreement/disagreement indicated.
  
  Originally published: 03.12.2020
  Revised: 12.01.2025
Is a qualifying face-to-face encounter required each time a new order/prescription for one of the specified items on the "Required Face-to-Face Encounter and Written Order Prior to Delivery List" is ordered?
- A qualifying face-to-face encounter is required within six (6) months of writing the order for any item on the "Required Face-to-Face Encounter and Written Order Prior to Delivery List".
  
  There are 2 exceptions to the face-to-face encounter:
  - Power Mobility Device (PMD) replacement during an item's useful lifetime is limited to situations involving loss or irreparable damage from a specific accident or natural disaster (e.g., fire, flood, etc.).
  - After an item's useful lifetime when an identical item is provided (any specific policy criteria must still be met).
  Originally published: 03.12.2020
  Revised: 12.01.2025

License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

AMA Disclaimer of Warranties and Liabilities.

CMS Disclaimer

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

Final Rule CMS-1713-F – Standard Written Orders

spacer